{'fraction_non_alphanumeric': 0.04360679970436068, 'fraction_numerical': 0.021433850702143386, 'mean_word_length': 4.481781376518219, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Simultaneous Assay of ρ-Coumaric Acid and Coumarin Co-encapsulated in Lipid-core Nanocapsules: Validation of an LC Analytical Method



 Lipid-Core Nanocapsules (LNC) containing co-encapsulated-coumaric acid
and coumarin are under development. However, there is a lack of analytical methods to assay these
bioactives in nanoformulations.


 The aim of this study was to validate an LC analytical method for the simultaneous determination
of ρ-coumaric acid and coumarin in lipid-core nanocapsules.



 The mobile phase was composed of acetonitrile:water (40:60 v/v) adjusted to pH 4 and a C-
18 reversed-phase column was used. Both bioactives were detected at 275 nm. Specificity, linearity,
range, precision and accuracy of the method were assessed, according to the official requirements.



 Nanocapsules containing ρ-coumaric and coumarin had monomodal particle size distribution,
spherical-shape and Z-average size of 207 ± 2 nm. LC method was specific, linear (5 to 30 µg.mL-1),
precise (RSD < 5%) and accurate (97 - 103%). It was applied to assay the content and encapsulation
efficiency of the bioactive substances in LNC, which were close to 0.5 mg.mL-1 and 72%, respectively.



 The proposed analytical method is reliable for the simultaneous assay of ρ-coumaric acid
and coumarin in nanocapsules and can be further used in their development.